Marijuana stock CannTrust Holdings has a 165 per cent upside, Echelon Wealth says
By Jayson Maclean – Cantech Letter
Cannabis licensed producer CannTrust Holdings (TSX:TRST) is trading at a big discount to its peers, says analyst Russell Stanley of Echelon Wealth Partners. In a client update on Tuesday, Stanley reiterates his Top Pick and “Speculative Buy” ratings for TRST and maintains his $18.50 target price.
Vaughan, Ontario’s CannTrust recently announced a supply agreement reached with medical cannabis producer Aleafia Health (TSXV:ALEF), under which Aleafia will recieve strains of high-quality starter genetics from CannTrust while the latter will take the right of first refusal to purchase product from Aleafia.